US 8778949
1-(2-phenoxymethylphenyl)piperazine compounds
granted A61KA61K31/495A61P
Quick answer
US patent 8778949 (1-(2-phenoxymethylphenyl)piperazine compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/495, A61P, A61P13/00, A61P19/02